Christopher T. Richie

Author

Also Known As

C. T. Richie, Christopher T. Richie, Christopher Richie, Christopher T Richie, Christopher T. Richie, Christopher T. Richie, Richie, C. T.

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

National Institute on Drug Abuse National Institutes of Health University of Helsinki The University of Texas MD Anderson Cancer Center National Institute of Mental Health

About

Christopher T. Richie is an author at National Institute on Drug Abuse specializing in medicine, cell biology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	17	2K
2	Cell Biology	11	11	695
3	Social Sciences	6	6	1.3K
4	Natural Sciences	2	2	73
5	Biology	1	1	21

Christopher T. Richie

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Chemogenetics revealed: DREADD occupancy and activation via converted clozapine Juan L. Gomez, Jordi Bonaventura, Wojciech G. Lesniak, Science PsychopharmacologyPharmacotherapySocial SciencesMolecular PharmacologyDrug Design	2017	1K
Direct wavefront sensing for high-resolution in vivo imaging in scattering tissue Kai Wang, Wenzhi Sun, Christopher T. Richie, Nature Communications	2015	289
Serotonergic versus Nonserotonergic Dorsal Raphe Projection Neurons: Differential Participation in Reward Circuitry Ross A. McDevitt, Alix Tiran‐Cappello, Hui Shen, Cell Reports	2014	202
Mesencephalic Astrocyte-derived Neurotrophic Factor (MANF) Secretion and Cell Surface Binding Are Modulated by KDEL Receptors Mark J. Henderson, Christopher T. Richie, Mikko Airavaara, Journal of Biological Chemistry Signal TransductionAutophagyKdel ReceptorsBrain-immune InteractionNeuroscience	2012	153
Lateral Hypothalamic GABAergic Neurons Encode Reward Predictions that Are Relayed to the Ventral Tegmental Area to Regulate Learning Melissa J. Sharpe, Nathan J. Marchant, Leslie R. Whitaker, Current Biology Neurobiological MechanismCognitive ScienceNeural MechanismBehavioral NeuroscienceDevelopmental Cognitive Neuroscience	2017	129
Gesicle-Mediated Delivery of CRISPR/Cas9 Ribonucleoprotein Complex for Inactivating the HIV Provirus Lee Ann Campbell, Lamarque M. Coke, Christopher T. Richie, Molecular Therapy	2018	126
Ventral Pallidum Is the Primary Target for Accumbens D1 Projections Driving Cocaine Seeking Thibaut R. Pardo-García, Constanza García‐Keller, Tiffany Penaloza, Journal of Neuroscience	2019	117
Cortical granule exocytosis in <i>C. elegans</i> is regulated by cell cycle components including separase Joshua N. Bembenek, Christopher T. Richie, Jayne M. Squirrell, Development	2007	106
Neuron-Specific Genome Modification in the Adult Rat Brain Using CRISPR-Cas9 Transgenic Rats Susanne Bäck, Julie Necarsulmer, Leslie R. Whitaker, Neuron Genome SurgeryGenetic EngineeringNeuron-specific Genome ModificationGenome EngineeringGene Editing	2019	97
The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse Mari Savolainen, Christopher T. Richie, Brandon K. Harvey, Neurobiology of Disease Knockout MouseCell AutophagyMitophagyA30p Transgenic MouseBeneficial Effect	2014	93

Page 1